Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

Trial Underway Testing Alzheimer’s-Schizophrenia Drug

A new clinical trial began in the U.K. in a test of an experimental drug to treat schizophrenia associated with Alzheimer’s disease. . . . → Read More: Trial Underway Testing Alzheimer’s-Schizophrenia Drug

Simple Cell Programming Designed for Gene Therapies

A simpler technique using nanoscale particles was shown in lab tests to deliver messenger RNA to reprogram cells for gene therapies, including changes in T-cells in the immune system now approved to treat a type of leukemia. . . . → Read More: Simple Cell Programming Designed for Gene Therapies

Trial Testing Nicotine Patch for Lung Inflammation

A clinical trial is underway testing a nicotine patch worn to help stop smoking as a treatment for a chronic inflammatory disease affecting the lungs. . . . → Read More: Trial Testing Nicotine Patch for Lung Inflammation

Engineered T-Cell Company Acquired for $11.9 Billion

A company developing personal cancer therapies that genetically engineer a patient’s immune system cells is being acquired in a deal valued at $11.9 billion. . . . → Read More: Engineered T-Cell Company Acquired for $11.9 Billion

Infographic – Vaccinations Changed the World

This chart, courtesy of Der Spiegel and Statista, shows how the incidence of several diseases has been reduced in the U.S. since the introduction of vaccines. . . . → Read More: Infographic – Vaccinations Changed the World

Clinical Trial Okayed for Parkinson’s Drug Implant

A maker of implants for long-term release of drugs to treat chronic diseases says the Food and Drug Administration approved a clinical trial to test its implant for Parkinson’s disease. . . . → Read More: Clinical Trial Okayed for Parkinson’s Drug Implant

Engineered Insulin-Producing Cells to Be Grown in Lab

A team from three universities is developing in the lab synthetic islet cells, the cells that produce insulin in the pancreas, for eventual transplantation in people with type 1 diabetes. . . . → Read More: Engineered Insulin-Producing Cells to Be Grown in Lab

Vaccines in Development for Opioid Combinations

Researchers studying the immune system as a weapon against opioid addiction say they can develop vaccines that block combinations of opioids, like those sold on the street. . . . → Read More: Vaccines in Development for Opioid Combinations

Study Testing Repurposed Drugs with Resistant Bacteria

A university team is investigating two current drug compounds for their ability to take on a new task, fighting bacteria becoming resistant to antibiotics. . . . → Read More: Study Testing Repurposed Drugs with Resistant Bacteria

AstraZeneca, Biotech Partner on Messenger RNA Therapies

Global drug maker AstraZeneca is acquiring an option to license the rights to a technology based on genetic material transcribed from DNA, for new respiratory disease treatments. . . . → Read More: AstraZeneca, Biotech Partner on Messenger RNA Therapies